Quarterly Financial Results for Q2 2026 – This 10-Q filing covers Intuitive Surgical's financial performance for the six-month period ended June 30, 2026, including revenue, operating results, and earnings data for both the second quarter and year-to-date periods Product and Service Revenue Breakdown – The filing contains detailed segmentation of revenue between product sales and service revenue…

Our analysis rates this filing NEUTRAL. Intuitive Surgical presents a balanced risk profile appropriate for a mature, established medical device company with global operations. The two identified risks (FX exposure and interest rate sensitivity) are routine operational concerns for multinational…

Concern level: MODERATE (3.8/10). Key factors: Foreign exchange exposure requiring active hedging with non-designated instruments creating earnings volatility (severity 4/10); Interest rate risk on available-for-sale securities portfolio with fair value exposure to rate changes (severity 3/10); Overall risk score of 4.2/10 indicates stable but monitored operational environment.

Notable risk changes: Document is incomplete XBRL filing header/metadata - substantive business content not fully accessible in provided excerpt; No material negative events, litigation, regulatory actions, or product safety issues disclosed in available filing sections; Standard derivative hedging disclosures for FX exposure indicate normal operational risk management, not new material concerns.

The model predicts ISRG will underperform the S&P 500 by about 0.0% over 30 days (model confidence 50%). This is model analysis for research, not investment advice.